EPCAM and neoplasm: In same tumor model, lnc-DILC expression in CD24+/EpCAM+ hepatic CSCs connects hepatic inflammation with liver CSC expansion, with low lnc-DILC levels to be predictive of early tumor recurrence and poor patient survival rates.